HSIC Stock Analysis: Buy, Sell, or Hold?
HSIC - Henry Schein Inc
$88.50
0.04 (0.05%)
▲
5d:
-1.41%
30d:
+4.7%
90d:
+20.41%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Get Alerted When HSIC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: HSIC shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: HSIC shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$120.32
Based on 7.8% avg growth
INTRINSIC VALUE TODAY
$74.71
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HSIC is currently trading at $88.50, which is considered extended relative to its 30-day fair value range of $85.08 to $89.00. The stock's valuation (Forward PE: 14.8) is in line with its historical norms (13.8). At these levels, the market is pricing in 2.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, HSIC is in a strong uptrend. The price is currently testing key support at $87.47. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: HSIC scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $98.19 (+10.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HSIC is in a strong uptrend. The price is currently testing key support at $87.47. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: HSIC scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $98.19 (+10.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$85.08 -
$89.00
Company Quality Score
40/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
27.1%
Protect Your Profits
Holding HSIC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (32/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($98.19)
- NEUTRAL: Market pricing in 2.2% annual earnings growth - fairly valued
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$85.08 -
$89.00
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$87.47
Resistance Level
$91.54
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.75
Wall Street Target
$98.19
(+10.9%)
Revenue Growth (YoY)
6.7%
Earnings Growth (YoY)
17.1%
Profit Margin
3.0%
Valuation Premium vs History
+2.2% premium
PE vs Historical
14.8 vs 13.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.2%
(market-implied from PE analysis)
1-Year Target
$90.45
(+2%)
2-Year Target
$92.44
(+4%)
3-Year Target
$94.47
(+7%)
3-Yr Target (if PE normalizes)
(PE: 15→14)
PE COMPRESSION
$88.36
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 11.6%)
$167.19
(+89%)
Base:
(SPY PE: 14.8, Growth: 11.6%)
$122.91
(+39%)
Bear:
(PE: 12.5, Growth: 11.6%)
$104.47
(+18%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (26x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 26.02 | Current EPS (TTM): $3.40
Bull Case
$171.67
(+94%)
Analyst growth 76.4%, PE expands to 28.6
Base Case
$156.06
(+76%)
Market implied 76.4%, PE stable at 26.0
Bear Case
$60.15
(-32%)
Severe decline -20.0%, PE contracts to 22.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 23, 2026 5:47 AM ET
Data refreshes hourly during market hours. Next update: 6:47 AM
Data refreshes hourly during market hours. Next update: 6:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HSIC showing a specific setup today?
Insider Activity (6 Months)
1
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
BUY
2026-03-30
Thomas C Popeck
SELL
1355 shares
2026-03-19
Kurt P Kuehn
SELL
2844 shares
2026-03-10
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$991 | 52 HOLD |
|
COR
Cencora Inc. |
STRONG BUY
14 analysts |
$373 | 52 HOLD |
|
CAH
Cardinal Health Inc |
BUY
17 analysts |
$271 | 51 HOLD |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 52 HOLD |
|
OMI
Owens & Minor Inc |
HOLD
6 analysts |
$6 | 46 HOLD |
Advanced HSIC Option Strategies
Professional options setups generated by AI based on today's HSIC price and gamma walls.
